Biodesix, Inc. (BDSX)
NASDAQ: BDSX · IEX Real-Time Price · USD
1.575
+0.015 (0.96%)
At close: May 17, 2024, 4:00 PM
1.650
+0.075 (4.76%)
After-hours: May 17, 2024, 5:21 PM EDT
Biodesix Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Biodesix stock have an average target of 3.15, with a low estimate of 2.80 and a high estimate of 3.50. The average target predicts an increase of 100.00% from the current stock price of 1.58.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Biodesix stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Initiates $2.8 | Strong Buy | Initiates | $2.8 | +77.78% | May 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +122.22% | Mar 4, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +122.22% | Dec 7, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +217.46% | May 12, 2022 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 20, 2022 |
Financial Forecast
Revenue This Year
66.56M
from 49.09M
Increased by 35.59%
Revenue Next Year
80.62M
from 66.56M
Increased by 21.13%
EPS This Year
-0.43
from -0.64
EPS Next Year
-0.33
from -0.43
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 68.8M | 86.6M | 104.4M |
| Avg | 66.6M | 80.6M | 101.4M |
| Low | 63.7M | 74.1M | 97.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 40.1% | 30.2% | 29.5% |
| Avg | 35.6% | 21.1% | 25.8% |
| Low | 29.8% | 11.3% | 20.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.43 | -0.28 | -0.17 |
| Avg | -0.43 | -0.33 | -0.16 |
| Low | -0.43 | -0.37 | -0.16 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.